These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2742010)

  • 21. Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial.
    Tesar GE; Rosenbaum JF; Pollack MH; Herman JB; Sachs GS; Mahoney EM; Cohen LS; McNamara M; Goldstein S
    J Clin Psychiatry; 1987 Oct; 48 Suppl():16-21. PubMed ID: 3312179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discontinuation of alprazolam treatment in panic patients.
    Fyer AJ; Liebowitz MR; Gorman JM; Campeas R; Levin A; Davies SO; Goetz D; Klein DF
    Am J Psychiatry; 1987 Mar; 144(3):303-8. PubMed ID: 3826428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs.
    Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
    J Clin Psychopharmacol; 2006 Oct; 26(5):519-23. PubMed ID: 16974197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder.
    Tesar GE; Rosenbaum JF; Pollack MH; Otto MW; Sachs GS; Herman JB; Cohen LS; Spier SA
    J Clin Psychiatry; 1991 Feb; 52(2):69-76. PubMed ID: 1993639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alprazolam in the treatment of panic disorders.
    Liebowitz MR; Fyer AJ; Gorman JM; Campeas R; Levin A; Davies SR; Goetz D; Klein DF
    J Clin Psychopharmacol; 1986 Feb; 6(1):13-20. PubMed ID: 2869059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns of response during placebo treatment of panic disorder.
    Mellergård M; Rosenberg NK
    Acta Psychiatr Scand; 1990 Apr; 81(4):340-4. PubMed ID: 2188481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacotherapeutic treatment of panic disorder in patients presenting with chest pain.
    Beitman BD; Basha IM; Trombka LH; Jayaratna MA; Russell B; Flaker G; Anderson S
    J Fam Pract; 1989 Feb; 28(2):177-80. PubMed ID: 2644392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of the usefulness and effectiveness of anxiolytic therapies in neoplastic diseases].
    Ziółko E; Knopik J; Bucior J; Foltyn W; Jastrzebska-Okoń K; Tomczyk A; Kempiński M
    Pol Merkur Lekarski; 2004 Jun; 16(96):561-4. PubMed ID: 15510897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequence of improvement in agoraphobia with panic attacks.
    Rifkin A; Pecknold JC; Swinson RP; Ballenger JC; Burrows GD; Noyes R; Dupont RL; Lesser I
    J Psychiatr Res; 1990; 24(1):1-8. PubMed ID: 2195163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison of the effect of alprazolam, imipramine and placebo in the treatment of panic disorders in Cali, Colombia].
    León CA; De Arango MV; Arevalo W; Calvo A; Montoya A; León A
    Acta Psiquiatr Psicol Am Lat; 1990; 36(1-2):59-72. PubMed ID: 2073024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discontinuation reactions to alprazolam in panic disorder.
    Pecknold JC
    J Psychiatr Res; 1993; 27 Suppl 1():155-70. PubMed ID: 8145176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The alprazolam to clonazepam switch for the treatment of panic disorder.
    Herman JB; Rosenbaum JF; Brotman AW
    J Clin Psychopharmacol; 1987 Jun; 7(3):175-8. PubMed ID: 3597803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alprazolam blockade of CO2-provoked panic in patients with panic disorder.
    Sanderson WC; Wetzler S; Asnis GM
    Am J Psychiatry; 1994 Aug; 151(8):1220-2. PubMed ID: 8037259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive style, alprazolam plasma levels, and treatment response in panic disorder.
    Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
    Depress Anxiety; 2008; 25(8):E18-26. PubMed ID: 17960759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multicenter double-blind efficacy and safety study comparing alprazolam, diazepam and placebo in clinically anxious patients.
    Cohn JB
    J Clin Psychiatry; 1981 Sep; 42(9):347-51. PubMed ID: 6115853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prior benzodiazepine exposure and benzodiazepine treatment outcome.
    Rickels K; Freeman EW
    J Clin Psychiatry; 2000 Jun; 61(6):409-13. PubMed ID: 10901337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alprazolam in the treatment of cardiology patients with atypical chest pain and panic disorder.
    Beitman BD; Basha IM; Trombka LH; Jayaratna MA; Russell BD; Tarr SK
    J Clin Psychopharmacol; 1988 Apr; 8(2):127-30. PubMed ID: 3286686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rebound anxiety in panic disorder patients treated with shorter-acting benzodiazepines.
    Herman JB; Brotman AW; Rosenbaum JF
    J Clin Psychiatry; 1987 Oct; 48 Suppl():22-8. PubMed ID: 2889722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alprazolam plasma concentrations and treatment response in panic disorder and agoraphobia.
    Lesser IM; Lydiard RB; Antal E; Rubin RT; Ballenger JC; DuPont R
    Am J Psychiatry; 1992 Nov; 149(11):1556-62. PubMed ID: 1415824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alprazolam in the treatment of panic attack patients with and without major depression.
    Pyke RE; Kraus M
    J Clin Psychiatry; 1988 Feb; 49(2):66-8. PubMed ID: 3338978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.